/ / / Method development & validation / / /

Method development and validation

With more than 20 years of drug discovery and development experience, Ricerca's chemistry and bioanalytical staffs are well qualified to assist clients in both method development and method validation. Our expertise allows exceptionally high reliability, with a linearity correlation coefficient of greater than 0.99, and levels of quantitation to five picograms/mL. To comply with the rapid turnaround times required by today's fast-paced drug development environment, Ricerca typically performs method evaluations in one to three days.

 

Recently validated methods include:

  • 17á-Ethynylestradiol
  • 5-fluorouracil (5-FU)
  • Amikacin
  • Avermectin / ivermectin
  • Cefquinome sulfate
  • Dextromethorphan and 3 metabolites
  • Doxycycline
  • Farnesylthiosalicylic acid (FTS)
  • Fentanyl
  • Flunixin
  • GHRP-1
  • Ketamine
  • Leuprolide
  • Lisinopril
  • Lovastatin
  • Mupirocin
  • Omeprazole
  • Oxybutynin
  • Phosphorothiate oligodeoxynucleotides
  • Sorivudine
  • Sulfadiazine
  • Thromboxane B2 (TXB2)
  • Thymosin á1
  • Tilmicosin
  • Trapidil
  • Trimethoprim
  • Zilpaterol